News

Podcast

The Basics of Head and Neck Cancer

Author(s):

Kristie L. Kahl

In this episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.

In this week’s episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, from the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research for the disease.

Head and neck cancer accounts for about 4 percent of all cancers in the United States, with more than 64 thousand people who have or will develop the disease this year.

In this week’s episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.

For more information, visit the Head and Neck Cancer Alliance's page on curetoday.com

Related Videos
Image of man with black hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Dr. Michael Moore
Dr. Michael Moore
Dr. Michael Moore
Dr. Michael Moore
Related Content
Two illustrations of people with tumors in the throat and jaw area.
October 19th 2024

Similar Survival Shown With Radiation Versus Robotic Surgery in HNC

Ashley Chan
Patients with a head and neck cancer subtype did not show differences in survival outcomes when treated with radiation versus transoral robotic surgery.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.
October 15th 2024

Keytruda Regimen May Improve Event-Free Survival in Head and Neck Squamous Cell Carcinoma

Darlene Dobkowski, MA
A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of a vial of treatment and a syringe with "out of stock," signifying the chemo shortage.
September 30th 2024

Chemo Shortage Increases Treatment Costs by 16% for Head and Neck Cancer

Darlene Dobkowski, MA
In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the cisplatin shortage.
head and neck cancer
September 5th 2024

Cancer Vaccine UV1 Shows No Survival Benefit in Head and Neck Cancer

Alex Biese
A trial showed no overall survival or progression-free survival benefit from the addition of UV1 to Keytruda in patients with HNSCC.